Cipher Pharmaceuticals (TSE:CPH) has released an update.
Cipher Pharmaceuticals is set to release its Q3 2024 financial results on November 7, 2024, followed by a conference call on November 8 to discuss the outcomes and company developments. With a strong portfolio primarily in dermatology, Cipher continues to manage clinical development and regulatory approvals, marketing its products across Canada, the U.S., and South America.
For further insights into TSE:CPH stock, check out TipRanks’ Stock Analysis page.
